Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program by unknown
Smith et al. BMC Public Health 2014, 14:1060
http://www.biomedcentral.com/1471-2458/14/1060RESEARCH ARTICLE Open AccessWomen’s intentions to self-collect samples for
human papillomavirus testing in an organized
cervical cancer screening program
Laurie W Smith1*, Fareeza Khurshed1, Dirk J van Niekerk1, Mel Krajden2,3, Sandra B Greene4, Suzanne Hobbs4,
Andrew J Coldman1,2, Eduardo L Franco5 and Gina S Ogilvie2,3Abstract
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, and many
organized screening programs are considering adopting it as primary testing. HPV self-collection has comparable
sensitivity to clinician collected specimens and is considered a feasible option in hard-to-reach women. We explored
women’s intentions to HPV self-collect for cervical cancer screening from a cohort participating in a Canadian
randomized controlled cervical cancer screening trial.
Methods: Women aged 25–65 were invited to complete an online survey assessing intentions to be screened with
HPV testing instead of the Pap smear. The survey was based in the Theory of Planned Behaviour and questions were
included to assess women’s intentions to self-collect for HPV. Demographic characteristics of women who intended to
self-collect were compared with those who did not. Demographic and scale variables achieving a p-value <0.1 in the
univariate and bivariate analyses were included in the stepwise logistic regression model. The final model was created
to predict factors associated with women’s intentions to self-collect an HPV specimen for cervical cancer. Odds ratios
were calculated with 95% confidence intervals to identify variables associated with a woman’s intention to self-collect
for cervical cancer screening.
Results: The overall survey response rate was 63.8% (981/1538) with 447 (45.6%) reporting they intended to self-collect,
versus 534 (54.4%) reporting they did not. In the univariate analysis, women with more than high school education
were more likely to self-collect. Women who intended to receive HPV testing versus the Pap smear were 1.94 times as
likely to be in favour of self-collection and those who intended to self-collect had significantly higher attitudinal scores
towards HPV self-collection. The adjusted odds ratio and 95% confidence interval from the multivariate analysis
demonstrated attitude towards self-collection was the only significant variable predicting a woman’s intention to
self-collect (OR 1.25; 95% CI: 1.22, 1.29).
Conclusions: The primary predictor of a woman’s intention to HPV self-collect for cervical cancer screening was her
attitude towards the procedure. From a program planning perspective, these results indicate that education and
awareness may be significant contributing factors to improving acceptance of self-collection and subsequently,
improving screening attendance rates.
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Over the past 50 years, screening with cytology (Pap smear)
has significantly decreased cervical cancer incidence and
mortality in countries where it has been practiced effect-
ively [1,2]. However, even where screening is widely
available, irregular or non-attendance to cervical screening
are significant barriers to further progress decreasing
cervical cancer rates in high-risk women [3]. In high
income countries, it is estimated that more than half of
women found to have cervical cancer have a history of
never, or infrequent screening [4,5].
It is now well established that persistent infection with a
high-risk genotype of the human papillomavirus (HPV) is
necessary for the development of cervical cancer and its
precursors [6,7]. Mounting evidence confirms DNA test-
ing for high-risk (hr)-HPV has higher sensitivity and nega-
tive predictive value for detection of cervical cancer or its
precursors than cytology testing [8]. Given this knowledge,
HPV testing is being considered for primary screening for
cervical cancer in organized programs [9,10]. The use of
HPV self-sampling for hard to reach and under-screened
populations with self-collection shows impressive sensitiv-
ity compared to clinician collected specimens for detect-
ing high-grade lesions [11,12]. For any number of reasons,
women may not participate in cervical cancer screening
(cultural, language, geographical and or access barriers for
example) and self-collection offers an alternative to at-
tending a visit with a clinician for screening. With self-
collection, women insert a sampling device into the
cervico-vaginal canal to collect the specimen themselves
in a private setting. Specimens are then dropped off or
mailed in for testing, thereby eliminating the need for a
gynaecologic exam by a clinician. Studies evaluating
women’s perceptions and uptake of self-sampling have
found that women generally feel positively about perform-
ing the procedure [12-14].
In British Columbia (BC), cervical cancer screening is
managed provincially, through a population based cervical
cancer screening program. In the past 30 years, incidence
and mortality rates for cervical cancer have declined and
remain low, reflecting the impact of organized population-
based screening [15]. In 2011, over 500,000 BC women
received Pap tests through the program. Despite program
success, of the 174 cases of invasive cervical cancers diag-
nosed in 2010, 42% of these women were screened more
than 5 years ago or had no history of being screened [15].
Hysterectomy adjusted participation rates for women
aged 20–69 years were 67.3% from 2009 to 2011 [15].
Studies have shown that self-sampling has the potential
to increase participation rates in hard to reach and
under-screened women in screening programs [8,13,16].
As organized settings begin to plan for the introduction
of primary HPV testing for cervical cancer screening, it
will be essential for program planners to address methodsto improve participation for women who do not routinely
attend for cervical cancer screening. The use of self-
collection offers an important opportunity to improve
uptake in non-attenders for screening. In this evaluation,
we determined women’s intentions to self-collect an HPV
specimen for cervical cancer screening in the setting of an
HPV testing based screening program.
Methods
Participants
Study participants for this evaluation were recruited
through the HPV FOCAL Study, a randomized con-
trolled, three-armed trial conducted in British Columbia
(ISRCTN79347302) [17,18]. Approval to conduct the
study was received from the BC Cancer Agency Re-
search Ethics Board (REB) (REB approval: H06-04032)
and all women in this evaluation consented to partici-
pate. Between January 2008 and March 2012, HPV
FOCAL recruited over 25,000 BC women aged 25–65
years of age through the organized provincial cervical
cancer screening program at the BC Cancer Agency.
Upon exit from one of the study arms, women with
email addresses were sent an invitation to complete the
online web-based survey and if necessary, they were sent
two additional invitation reminders to complete the
survey. FluidSurveys (www.fluidsurveys.com) was the
online survey software utilized for the purposes of this
evaluation. Participants entered data on the website which
was then downloaded into CSV files for analysis.
Survey tool
The Theory of Planned Behaviour (TPB) [19,20] was used
as the theoretical framework for the survey in this study.
This framework has been applied extensively to assess
health behaviours and attendance at screening [21-23].
TPB proposes that the most important determinant of any
behaviour is the person’s intention to perform that behav-
iour [21]. The Theory of Planned Behaviour is considered
an important model of attitude-behaviour relationships,
with the constructs of this framework showing to contri-
bute to the prediction of intentions and subsequent
behaviour [24]. All items included in the survey were
constructed from literature review and feedback from
content experts. The survey was reviewed by an expert in
TPB and subsequently pilot tested on a small number of
women in the target demographic after which it was
revised and re-piloted again prior to implementation to
eligible women.
At the beginning of the survey, women were provided
with some brief background information on human papil-
lomavirus, which included information on HPV prevalence,
transmission, its role in cervical cancer and the reasons for
use of HPV testing in cervical cancer screening (See
Appendix 1). The survey assessed women’s intentions to be
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women’s intention to be screened for HPV at 4 year screen-
ing intervals, and; screening for HPV at 4 year intervals
commencing at 25 years of age [25]. As part of the survey,
women were informed that HPV specimens could be self-
collected vaginally, without needing to see a health care
provider or undergo a pelvic examination for cervical
cancer screening. In addition to demographics, variables
assessing the three specific elements that predict behaviour
intentions were measured with seven point Likert scales.
These included: attitude towards the behaviour, perceived
behavioural control, and subjective norms to the behaviour.
For the purposes of this analysis, “behaviour” refers to a
woman’s willingness to collect her own sample for HPV
testing. Attitudes towards the behaviour are one’s perspec-
tive on the value and utility of the behaviour. Perceived
behavioural control refers to an individual’s perception of
their ability to control the behaviour, and subjective norms
to behaviour are one’s belief about how people they care
about will view the behaviour in question (in other words,
social pressure to perform or not perform the behaviour in
question) [21]. Each variable can be measured either dir-
ectly (asking about overall attitude), or indirectly (by asking
respondents about specific beliefs about the behaviour),
with both approaches to variable measurement make differ-
ent assumptions about underlying cognitive structures [20].
Response rate
Surveys were reviewed for completeness and where du-
plicate surveys were identified, the first complete survey
was used in the analysis and the second was discarded.
Response rate was calculated according to the American
Association for Public Opinion Research [26]. Response
rate for this survey was number of complete surveys,
divided by number of complete surveys plus partially
complete, refusal and log on without completion.
Analysis
The primary endpoint for this evaluation was response to
the statement ‘I would be willing to collect my own sample/
specimen for cervical cancer screening’. Participants
responded to the statement with a seven point Likert scale
(strongly disagree, to strongly agree). The responses were
dichotomized so that those who responded >4 were coded
as ‘intending to self-collect’ and participants who responded
≤4 as ‘not intending to self-collect’. In addition, women’s
attitudes towards self-collection were evaluated from re-
sponses to the statement ‘Collecting my own sample for
cervical cancer screening would be… (accurate vs. inaccurate;
safe vs. unsafe; protect my health vs. harm my health; accept-
able vs. unacceptable)’.
Demographic characteristics of survey responders and
non-responders were compared using data collected from
the larger HPV FOCAL Trial. All FOCAL Trial participantsare asked to complete a demographic questionnaire upon
entry, with questions addressing such variables as marital
status, ethnicity, smoking and sexual history. Descriptive
and univariate analyses of demographic characteristics of
survey respondents were performed, including median age,
marital status, education, sexual history, ethnicity and
smoking history, categorized by women who intend to self-
collect, versus those who did not. Continuous variables were
compared with Student’s t-tests and Kruskal-Wallis tests as
appropriate and categorical variables were compared with
Chi-Square test. Women’s intention to self-collect a sample
for cervical cancer screening was calculated with 95%
confidence intervals and variables with p-values <0.05 were
deemed significant.
Scale items were analyzed according to methods for the
Theory of Planned Behaviour [20]. See Additional file 1 for
analysis details. In summary, items were re-anchored and
re-coded as needed and if items in scales achieved agree-
ment as measured by Cronbach’s alpha >0.5, a composite
variable was created and then included in the univariate
and where appropriate, multivariate analysis. If scales did
not achieve a Cronbach’s alpha >0.5, subscales which did
achieve agreement were created and included in analysis.
Demographic characteristics of women who intended
to self-collect were compared with those who did not
intend to self-collect with Chi-square, Student’s t-test
and Kruskal-Wallis as appropriate. Multi-collinearity of
psychological scales that achieved an item correlation
with Cronbach’s alpha >0.5 was assessed with Pearson
correlation coefficient. Overall scale scores and mean
scores with standard deviations for scale results between
those who intended to self-collect and those who did
not intend to self-collect were calculated. Mean results
with standard deviations between scales that had ac-
ceptable agreement (Cronbach’s alpha >0.5) and no
collinearity were compared using Student’s t-tests.
Demographic (including age, marital status, cultural
background, number of male sexual partners, smoking
history) and scale variables that achieved a p-value <0.1
in the univariate and bivariate analyses were included in
the stepwise logistic regression model. The model was
created to predict factors associated with women’s
intentions to self-collect a specimen for cervical cancer.
The dependent variable for the model was ‘intention to
self-collect’ (0 = did not intend; 1 = intended). Logistic
regression analysis was conducted and odds ratios cal-
culated for significant variables with 95% confidence
intervals to identify correlates of a woman’s intention to
self-collect for cervical cancer screening. Analyses were
conducted with SAS 9.3.
Results
The survey was administered from May through September
2011. Of the 2,459 women who had completed participation
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able for, and invitations to complete the survey were sent to
2,016 women (eligible population) (Figure 1). Of the 2,016
eligible women, 1,035 were not surveyed. This includes 191
who logged on but did not respond to any questions; 294
who submitted partially complete surveys; 478 emails were
returned undeliverable and 72 responded to the invite, but
declined participation. In total, 981 completed surveys are
included in the analysis, for an overall response rate of
48.7% (981/2,016) for all women from the eligible popula-
tion, and 63.8% (981/1,538) for all women who received the
invite for survey completion.
The results demonstrated no significant differences
between socio-demographic characteristics of survey re-
sponders and non-responders (Table 1). Survey respondents
were between 25 and 65 years of age, with a mean age of
45.0 years (standard deviation [SD] 10.0). More than 85% of
women self-reported having more than high school educa-
tion of which 50% reported achievement of a University
degree. The majority of responders, self-reported Caucasian,
black or South Asian background (>89%); 2.4% of women
were Aboriginal and 8.3% were Chinese. More than 56%
reported having 5 or fewer lifetime sexual partners. Six
percent were current smokers and 36.1% reported smoking
at some time in their lives.
The Cronbach’s alpha was 0.96 (96%) indicating
consistency of responses to the attitude measurements
for self-collection.
Of the 981 women who completed the surveys, 447
(45.6%) reported they intended to self-collect, versus 534
(54.4%) who reported they did not intend to self-collect
(Table 2). Women who had more than high school educa-
tion were more likely to self-collect than women with less
than high school education (p-value =0.02). There were no
significant differences between marital status, sexual his-
tory, ethnic origin, smoking status age of recruitment ofFigure 1 Study Flowchart and participant distribution.women who intended to self-collect vs. those who did not
(p-value >0.05).
A woman’s responses to other questions in the survey
can be directly correlated with her opinions regarding
self-sampling. Variables that have a significant differ-
ence in scores between those who intend to self-collect
and those who do not, include subjective norms indirect
(p-value = 0.03) and direct (p-value <0.01), which may
indicate that the opinions of those who are important to
them, as well as others such as family physician, friends,
partner, the BC Cancer Agency, may influence the
woman’s decision to self-collect or not (Table 3).
Women who intended to self-collect had significantly
higher attitudinal scores, indicating belief that self-
collection was accurate, safe, protective and acceptable
(p-value < 0.001). There was no difference between
women who intended to self-collect and those who did
not with regards to comfort sharing results with part-
ners (p-value = 0.28) or reported perceived behavioural
control (p-value = 0.10).
We also examined the relationship between a woman’s
intent to self-collect, and her intent to receive HPV test-
ing versus the Pap smear. Those who intend to receive
HPV testing were 1.94 times as likely to be in favour of
self-collection (95% CI: 1.35; 2.80, p = 0.0003) than
women who did not intend to receive HPV testing.
Based on the univariate and bivariate analyses, vari-
ables included in the regression model were those with
a p-value less than 0.1 including: the psychological vari-
ables for indirect and direct subjective norms; perceived
behavioural control; intent to receive HPV testing ver-
sus the Pap smear; and attitude towards self-collection.
Age and education were also included in the model. We
used a stepwise regression analysis that did not retain
insignificant explanatory variables. The only variable of
significance in predicting a woman’s intention to self-
Table 1 Comparison of demographic characteristics survey respondents vs. non-respondents1
Characteristic Group Study invitees N (%) Respondent N (%) Non-respondent N (%) p-Value
Overall 2016 981 1035
Age, Recruitment Mean (SD) 45.1 (10.1) 45.0 (10.0) 45.3 (10.2) 0.5248
Median (IQR)2 45.0 (38.0, 53.0) 45.0 (38.0,53.) 46.0 (37.0, 53.0)
Education Missing 130 130 0.2330
<High School 31 (1.6%) 11 (1.1%) 20 (2.2%)
High School (Complete) 248 (13.1%) 122 (12.4%) 126 (13.9%)
Trade/College/ University (Incomplete) 692 (36.7%) 356 (36.3%) 336 (37.1%)
University graduate 584 (31.0%) 311 (31.7%) 273 (30.2%)
University advanced degree 331 (17.6%) 181 (18.5%) 150 (16.6%)
Sexual partners - ever Missing 151 151 0.8514
0 4 (0.2%) 1 (0.1%) 3 (0.3%)
1 362 (19.4%) 185 (18.9%) 177 (20.0%)
2 to 5 693 (37.2%) 364 (37.1%) 329 (37.2%)
6 to 10 408 (21.9%) 221 (22.5%) 187 (21.2%)
11 to 50 376 (20.2%) 198 (20.2%) 178 (20.1%)
>50 22 (1.2%) 12 (1.2%) 10 (1.1%)
Cultural background Missing 128 128 0.2879
Chinese 175 (9.3%) 81 (8.3%) 94 (10.4%)
Aboriginal 46 (2.4%) 24 (2.4%) 22 (2.4%)
Caucasian and other 1667 (88.3%) 876 (89.3%) 791 (87.2%)
Smoke, Now Missing 188 188 0.1908
No 1707 (93.4%) 923 (94.1%) 784 (92.6%)
Yes 121 (6.6%) 58 (5.9%) 63 (7.4%)
Smoke, Ever Missing 184 184 0.4382
No 1156 (63.1%) 627 (63.9%) 529 (62.2%)
Yes 676 (36.9%) 354 (36.1%) 322 (37.8%)
1Pearson’s Chi Square, Student’s t-test; 2Kruskal-Wallis.
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self-collection (OR 1.25; 95% CI: 1.22, 1.29) (Table 4).
Discussion
It is anticipated that vaccination against oncogenic HPV
types will decrease the incidence of cervical cancer on a
population level in the future when girls who have been
vaccinated begin to reach the age for cervical cancer
screening sometime in the next 10–15 years. However,
despite the promising effects widespread HPV vaccin-
ation will have, screening for cervical cancer will still
need to occur. With the growing body of evidence dem-
onstrating the efficacy of primary HPV testing with cy-
tology triage for detecting precancerous lesions and
subsequent decreases in the incidence of cervical cancer
[27], it is anticipated programmatic changes will occur
in many organized settings from primary screening with
the Pap smear, to HPV testing. However, a paradigm
shift to more sensitive technologies will not necessarily
improve attendance rates for under-screened women. Inorder to decrease population incidence of cervical cancer
and pre-cancerous lesions in vaccinated and or unvac-
cinated cohorts, improved screening attendance rates
must be realized. Therefore, alternative methods such as
self-collection for HPV are being explored to improve
participation rates. Prior to implementation of this
approach, a component of program planning should
include examination of women’s acceptance of, and
willingness to participate in screening with HPV self-
collection in the organized setting, as well as healthcare
provider and population education.
In our study, of the 981 women who completed the
survey, 447 (45.6%) indicated they intended to self-collect
versus 534 (54.4%) reporting they did not intend to self-
collect. Overall, the results of this analysis show that regard-
less of other variables, the primary predictor of a woman’s
intention to HPV self-collect for cervical cancer screening
is her attitude towards the procedure. This is important
from a program planning perspective, indicating that con-
certed efforts towards comprehensive education and
Table 2 Univariate demographic characteristics of women who intend to self-collect compared to those who do not1
Variable Group SC25 < =4 Do not intend to self-collect SC25 > 4 Intend to self-collect Overall p-value
Overall Overall 534 (54.4%) 447 (45.6%) 981 0.0055
Marital status Divorced 56 (10.5%) 52 (11.6%) 108 (11.0%) 0.5366
Married 317 (59.4%) 281 (62.9%) 598 (61.0%)
Never married 69 (12.9%) 43 (9.6%) 112 (11.4%)
Widowed 5 (0.9%) 2 (0.4%) 7 (0.7%)
Common-law 50 (9.4%) 41 (9.2%) 91 (9.3%)
Did not answer 37 (6.9%) 28 (6.3%) 65 (6.6%)
Education <High School 85 (15.9%) 48 (10.7%) 133 (13.6%) 0.0193
More than High School 499 (84.1%) 399 (89.3%) 848 (86.4%)
Sexual partners 0 0 (0.0%) 1 (0.2%) 1 (0.1%) 0.1908
1 116 (21.7%) 69 (15.4%) 185 (18.9%)
2-5 189 (35.4%) 175 (39.1%) 364 (37.1%)
6-10 116 (21.7%) 105 (23.5%) 221 (22.5%)
11-50 105 (19.7%) 93 (20.8%) 198 (20.2%)
51-99 7 (1.3%) 3 (0.7%) 10 (1.0%)
>99 1 (0.2%) 1 (0.2%) 2 (0.2%)
Ethnic origin Chinese 50 (9.4%) 31 (6.9%) 81 (8.3%) 0.3876
Aboriginal 13 (2.4%) 11 (2.5%) 24 (2.4%)
Other 471 (88.2%) 405 (90.6%) 876 (89.3%)
Smoke - Ever No 339 (63.5%) 288 (64.4%) 627 (63.9%) 0.7585
Yes 195 (36.5%) 159 (35.6%) 354 (36.1%)
Age (Recruitment) Median (IQR)2 44 (37–52) 46 (38–54) 45 (38–53) 0.0927
1Chi Square test. 2Kruskal-Wallis.
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HPV testing in preventing cancer could be the significant
contributing factors to improving acceptance of self-
collection and subsequently improving screening attend-
ance rates.
In the current study, when asked if they would be will-
ing to collect their own specimen for HPV, more than
half of all responders were not willing to self-collect.
This rate was higher than expected, given results of pre-
viously published literature which found that women
generally approved of the procedure and had positive at-
titudes towards it [12,14,28]. There are several potential
reasons for this. Women in our study are currentlyTable 3 Comparison of scale results between women intendin
Variable Overall (SD) Do not intend
SC25 < =4 Mea
Subjective norms indirect 34.79 (31.93) 32.71 (32.36)
Age 44.96 (9.99) 44.49 (9.93)
Contacting partners 12.59 (2.25) 12.52 (2.33)
Perceived behavioural control 23.41 (4.12) 23.21 (4.04)
Attitude towards self-collection 17.15 (7.62) 12.91 (6.30)
Subjective norms 11.01 (2.57) 10.78 (2.61)actively engaged in cervical cancer screening, and thus
are very comfortable and even prefer having a clinician
collect their specimens for screening. This is important,
because if self-collection is used as part of a regular
screening program, our findings indicate need for
substantial education and support for women already
engaged in screening. In addition, in our study, we
explored women’s willingness to self-sample through the
survey and did not provide an extensive description
about how the procedure is performed, nor were women
provided the opportunity to self-collect. In our previous
study, Ogilvie et al., [25] found that among the predic-













Table 4 Predictors of Intention to self-collect for cervical cancer screening with HPV testing using logistic regression
Variable Odds ratio 95% Confidence limits
Attitudes to self-collection (SC24) 1.254 1.220 1.289
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testing from highly regarded health agencies or health
practitioners. The results of this evaluation correlate
with those findings, indicating that providing women
with sufficient information and education about HPV
self-collection is a significant factor contributing to will-
ingness to perform the procedure. The authors recom-
mended that substantial efforts should be made to
ensure women are educated about the safety and accur-
acy of HPV testing as these are critical factors to
women’s acceptance of HPV testing [25].
In this study, the women who intended to be screened
with primary HPV testing compared to the Pap smear
were significantly more likely to be in favour of self-
collection. This is relevant, given our previous study
showed that 84.2% of women intended to be screened
for cervical cancer with HPV testing versus the Pap test
[25]. However, our previous study also showed that
intention to be screened with HPV decreased to 54.2%
when the interval was extended to every 4 years and de-
creased further to 51.4% when HPV testing every 4 years
commencing at age 25 was proposed [25].
The results of the descriptive analysis showed women
who had more than high school education were more
likely to self-collect than women with less than high
school education. However, education was not signifi-
cant in the adjusted regression model and the only pre-
dictor of significance was a woman’s attitude towards
self-collection. This is consistent with other published
research demonstrating no definitive associations be-
tween a woman’s attitude towards self-collection and
demographic variables such as education, socioeconomic
status and age [12,29]. Historically, under-screened
women in organized programs are often from lower
socioeconomic status and/or have lower education levels
[3,30]. This finding is important and suggests that re-
gardless of socioeconomic factors, efforts made to ad-
dress women’s attitudes towards self-sampling are
critical to successful implementation of the approach.
From a program planning perspective, adoption of a
variety of appropriate knowledge translation activities
will be critical to successful adoption of alternative ap-
proaches to screening and improved attendance rates.
This survey was administered to women who are at-
tendees of the British Columbia, organized cervical can-
cer screening program and participants of a randomized
controlled trial (RCT) [17,18]. All women surveyed had
a recent cervical screen (less than 3 years) demonstrat-
ing a level of comfort receiving screening from aclinician. This indicates that these survey results are
highly generalizable for screening programs looking to
broadly adopt self-collection, and offer it to women as
an option for cervical cancer screening. Although the
comparison of results between survey respondents and
non-respondents showed there were no significant
demographic differences, because our survey primarily
included women engaged in a screening program, the
findings of the survey can only be generalized with cau-
tion to the population of women who do not routinely
attend for cervical cancer screening. Over 50% of our
survey participants reported having a university degree,
and 89% reported Caucasian/other which may not
necessarily reflect the target population for whom self-
collection may initially be offered. In addition, this study
was conducted in an urban setting, with less representa-
tion of women from rural or remote settings. Given
self-collection for cervical cancer screening is also
considered to be an option to improve rates in the
under-screened, who often have lower education are
from ethnic minorities, and or are from rural/remote
settings, further examinations need to be targeted to
these populations specifically.
To our knowledge, women in this survey had no
experience performing cervical sample self-collection.
Other trials demonstrating positive attitudes towards
self-collection assessed women’s attitudes towards the
procedure after having obtained a self-collected speci-
men [12,14]. A recent meta-analysis examining pub-
lished research comparing self-collected HPV testing in
women who did not routinely participate in screening
programs showed high acceptance levels for self-
collection in this population [14] demonstrating the
importance of specifically targeting the under-screened
and providing the opportunity to perform the procedure
in explorations of self-collection as an alternative
method in organized settings. Further research is recom-
mended to specifically target the under-screened in
British Columbia with the opportunity to participate in
self-collection procedures to evaluate not only attitudes
and acceptance, but also screening participation rates.
Conclusion
This study demonstrates that the primary predictor of a
woman’s intent to self-collect a vaginal sample for HPV
testing is her attitude towards this procedure. Although
the women in this study are currently engaged in
clinician-based screening in an organized program, these
findings illustrate that comprehensive education is
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to both keep women engaged in screening and to im-
prove screening attendance rates. Culturally competent
educational materials should be available in a variety of
formats to include information about HPV, its associ-
ation with cervical cancer, and the importance of screen-
ing. Additionally, to ensure acceptance of self-collection
by women, they should be provided with information
regarding the ease, effectiveness and safety of the
procedure. Further research is recommended to explore
the attitudes surrounding, and intentions to self-collect,
for women who do not regularly attend for clinician-
based cervical cancer screening.
Additional file
Additional file 1: Theory of Planned Behaviour.Appendix 1
Introductory information provided to survey respondents
Here is some background information for you to con-
sider before you complete this survey.
The human papillomavirus (HPV) is a common virus
that can infect the cervix (part of a woman’s womb). It is
now known to be the cause of cervical cancer. Women
develop HPV infections in the cervix after having sexual
activity with a partner who is infected with HPV. How-
ever, HPV is so common that over 75% of sexually-active
women will have an HPV infection of their cervix some-
time during their life. Most women who find out they
have an HPV infection in the cervix after the age of 30,
were infected with HPV years before. Over 90% of women
who are infected with HPV in the cervix get rid of the
infection naturally. It is only women who have longstand-
ing infections with certain types of HPV who may be at
risk for developing cervical cancer. Women may not have
known it in the past, but it is these same HPV infections
that are the most common reason for abnormal Pap
smears.
Right now in BC, women start cervical cancer screening
once they become sexually active. We now know that
testing for HPV infections in the cervix is more accurate
than the Pap smear for predicting whether or not a
woman will develop cervical cancer.
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